Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2022 09:30 ET | Source: Vivos Inc.

Vivos Inc Implements Multiple Patient IsoPet® Therapy Day

Richland WA, April 21, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce a combined IsoPet® therapy schedule into one treatment day, allowing for one production run...
June 24, 2021 09:30 ET | Source: Vivos Inc.

Vivos Inc Initiates Isopet® Therapy in Horses

Richland WA, June 24, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Vivos Inc announced that it has completed the first IsoPet® therapy on an equoid tumor. It was administered at the University...
December 01, 2020 09:30 ET | Source: Vivos Inc.

Vivos Inc Extends it Intellectual Property Protection

Richland WA, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that it received the Patent Cooperation Treaty (PCT) International Search Report on our patent...
May 31, 2018 06:00 ET | Source: Vivos Inc.

Vivos Inc Successfully Treats Canine Sarcoma with IsoPet™ (RadioGel™)

Richland, WA, May 31, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) successfully treated canine soft tissue sarcoma with its proprietary IsoPet™ (RadioGel™), a hydrogel liquid containing tiny...